company background image
A007570

Ilyang PharmaceuticalLtd KOSE:A007570 Stock Report

Last Price

₩18.85k

Market Cap

₩340.9b

7D

1.3%

1Y

-12.9%

Updated

26 Jan, 2023

Data

Company Financials

Ilyang Pharmaceutical Co.,Ltd

KOSE:A007570 Stock Report

Mkt Cap: ₩340.9b

A007570 Stock Overview

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea.

A007570 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

My Notes

New

Notes are coming soon

Ilyang Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ilyang PharmaceuticalLtd
Historical stock prices
Current Share Price₩18,850.00
52 Week High₩29,600.00
52 Week Low₩16,200.00
Beta0.0089
1 Month Change-5.75%
3 Month Change5.90%
1 Year Change-12.93%
3 Year Change-22.43%
5 Year Change-54.41%
Change since IPO224.10%

Recent News & Updates

Recent updates

Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?

Apr 04
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?

Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?

Mar 14
Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?

Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely

Mar 14
Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely

Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?

Feb 22
Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?

Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?

Feb 01
Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?

Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?

Jan 11
Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?

Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly

Dec 24
Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

Dec 06
A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Nov 18
Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Shareholder Returns

A007570KR PharmaceuticalsKR Market
7D1.3%1.5%2.6%
1Y-12.9%-13.0%-11.8%

Return vs Industry: A007570 matched the KR Pharmaceuticals industry which returned -13% over the past year.

Return vs Market: A007570 underperformed the KR Market which returned -11.8% over the past year.

Price Volatility

Is A007570's price volatile compared to industry and market?
A007570 volatility
A007570 Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.4%
10% most volatile stocks in KR Market10.6%
10% least volatile stocks in KR Market3.1%

Stable Share Price: A007570 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: A007570's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1946675Dong-Yeon Kimhttps://www.ilyang.co.kr

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.

Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary

How do Ilyang PharmaceuticalLtd's earnings and revenue compare to its market cap?
A007570 fundamental statistics
Market Cap₩340.94b
Earnings (TTM)₩21.26b
Revenue (TTM)₩389.45b

16.0x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A007570 income statement (TTM)
Revenue₩389.45b
Cost of Revenue₩168.34b
Gross Profit₩221.11b
Other Expenses₩199.85b
Earnings₩21.26b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.18k
Gross Margin56.78%
Net Profit Margin5.46%
Debt/Equity Ratio28.8%

How did A007570 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

17%

Payout Ratio